The Oncology Institute, Inc. (TOIIW)
USD 0.02
(-17.27%)
USD 0.02
(-17.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 86.82 Million USD | -15.44% |
| 2022 | 102.68 Million USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 6.56 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 88.38 Million USD | 1.8% |
| 2024 Q2 | 89.95 Million USD | 1.77% |
| 2023 FY | 86.82 Million USD | -15.44% |
| 2023 Q1 | 104.39 Million USD | 1.67% |
| 2023 Q2 | 110.33 Million USD | 5.69% |
| 2023 Q3 | 111.26 Million USD | 0.85% |
| 2023 Q4 | 86.82 Million USD | -21.97% |
| 2022 Q4 | 102.68 Million USD | 1.77% |
| 2022 FY | 102.68 Million USD | 0.0% |
| 2022 Q3 | 100.89 Million USD | 590.41% |
| 2022 Q2 | 14.61 Million USD | 1.42% |
| 2022 Q1 | 14.4 Million USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 6.48 Million USD | -1.16% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q2 | 4.69 Million USD | -27.68% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | 6.56 Million USD | 0.0% |
| 2020 Q4 | 6.56 Million USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 93.533% |
| Addus HomeCare Corporation | 124.13 Million USD | 30.053% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -24.924% |
| Amedisys, Inc. | 346.76 Million USD | 74.961% |
| American Oncology Network, Inc. | 120.44 Million USD | 27.912% |
| Astrana Health, Inc. | 296.26 Million USD | 70.693% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 93.197% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | 18.573% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -835.426% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -3160.458% |
| COMPASS Pathways plc | 28.75 Million USD | -201.93% |
| DocGo Inc. | 15.16 Million USD | -472.658% |
| The Ensign Group, Inc. | 1.78 Billion USD | 95.135% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -672.817% |
| InnovAge Holding Corp. | 100.49 Million USD | 13.603% |
| Assure Holdings Corp. | 505 Thousand USD | -17093.267% |
| The Joint Corp. | 2 Million USD | -4241.3% |
| LifeStance Health Group, Inc. | 280.28 Million USD | 69.022% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -22662.748% |
| ModivCare Inc. | 983.75 Million USD | 91.174% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -72875.903% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -4837.181% |
| Option Care Health, Inc. | 1.05 Billion USD | 91.783% |
| P3 Health Partners Inc. | 108.31 Million USD | 19.842% |
| P3 Health Partners Inc. | 108.31 Million USD | 19.842% |
| The Pennant Group, Inc. | 312.51 Million USD | 72.217% |
| Surgery Partners, Inc. | 2.03 Billion USD | 95.73% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | 0.0% |